TÜRKELİ, A. Et Al. 2021. Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models. EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.22, no.1 .

TÜRKELİ, A., YILMAZ, Ö., KARAMAN, M., Kanik, E. T., Firinci, F., İNAN, S., ... YÜKSEL, H.(2021). Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models. EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.22, no.1.

TÜRKELİ, AHMET Et Al. "Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models," EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.22, no.1, 2021

TÜRKELİ, AHMET Et Al. "Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models." EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.22, no.1, 2021

TÜRKELİ, A. Et Al. (2021) . "Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models." EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.22, no.1.

@article{article, author={AHMET TÜRKELİ Et Al. }, title={Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/beta-catenin signaling axis in experimental asthma models}, journal={EXPERIMENTAL AND THERAPEUTIC MEDICINE}, year=2021}